Evaluation of anti-CD160 antibodies in "in vivo" models.

Forscher/innen

Filtern

Mª LUISA DEL

RÍO GONZÁLEZ

Verantwortlich

JOSE IGNACIO

RODRÍGUEZ BARBOSA

Verantwortlich

Publikationen im Zusammenhang mit dem Projekt (2)

Nach Typologie anzeigen

2023

1. Genetic deletion of HVEM in a leukemia B cell line promotes a preferential increase of PD-1- stem cell-like T cells over PD-1+ T cells curbing tumor progression

   Frontiers in Immunology

2022

1. The impact of CD160 deficiency on alloreactive CD8 T cell responses and allograft rejection

   Translational Research